Lorbrena
Active substance: lorlatinib
TABLET, FILM COATED · LORLATINIB 25 mg/1
United StatesActive
Marketing holder: U.S. Pharmaceuticals
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- LORLATINIB · 25 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12092-3262-7bfc-b63d-afd286becfb5,01a12095-365e-7591-b282-d5d81cf72b0e,01a1209a-37a6-70bc-8d8d-a182f01e1fa0;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 63539-927
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 63539-927 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63539-927 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63539-927 · Verified 2026-10-09 · open in source